Humana Inc. (NYSE:HUM) Shares Sold by Stifel Financial Corp

Stifel Financial Corp trimmed its stake in shares of Humana Inc. (NYSE:HUM - Free Report) by 30.7% in the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 41,214 shares of the insurance provider's stock after selling 18,218 shares during the quarter. Stifel Financial Corp's holdings in Humana were worth $10,457,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. State of Tennessee Department of Treasury increased its stake in Humana by 32.2% in the 4th quarter. State of Tennessee Department of Treasury now owns 44,789 shares of the insurance provider's stock valued at $11,363,000 after buying an additional 10,919 shares during the period. TD Waterhouse Canada Inc. increased its stake in shares of Humana by 5.4% during the fourth quarter. TD Waterhouse Canada Inc. now owns 9,807 shares of the insurance provider's stock worth $2,487,000 after acquiring an additional 506 shares during the period. Transce3nd LLC purchased a new position in Humana during the fourth quarter worth about $38,000. MetLife Investment Management LLC lifted its position in Humana by 1.8% in the fourth quarter. MetLife Investment Management LLC now owns 31,872 shares of the insurance provider's stock valued at $8,086,000 after purchasing an additional 560 shares during the period. Finally, Norinchukin Bank The boosted its holdings in Humana by 10.2% in the 4th quarter. Norinchukin Bank The now owns 5,528 shares of the insurance provider's stock valued at $1,403,000 after purchasing an additional 510 shares in the last quarter. 92.38% of the stock is currently owned by hedge funds and other institutional investors.

Humana Trading Up 1.5 %

Shares of HUM traded up $3.76 during trading hours on Friday, hitting $259.80. The stock had a trading volume of 585,300 shares, compared to its average volume of 1,748,409. The firm has a market cap of $31.36 billion, a P/E ratio of 26.11, a P/E/G ratio of 2.05 and a beta of 0.62. The company has a debt-to-equity ratio of 0.68, a quick ratio of 1.76 and a current ratio of 1.76. The company's fifty day simple moving average is $266.20 and its 200 day simple moving average is $270.62. Humana Inc. has a 12-month low of $213.31 and a 12-month high of $406.46.

Humana (NYSE:HUM - Get Free Report) last posted its quarterly earnings results on Wednesday, April 30th. The insurance provider reported $11.58 EPS for the quarter, beating the consensus estimate of $10.07 by $1.51. Humana had a net margin of 1.02% and a return on equity of 11.70%. The firm had revenue of $32.11 billion for the quarter, compared to analyst estimates of $32 billion. During the same quarter last year, the firm posted $7.23 earnings per share. Humana's revenue for the quarter was up 8.4% compared to the same quarter last year. Equities research analysts forecast that Humana Inc. will post 16.47 EPS for the current fiscal year.

Humana Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Friday, July 25th. Shareholders of record on Friday, June 27th will be given a $0.885 dividend. This represents a $3.54 annualized dividend and a yield of 1.36%. The ex-dividend date is Friday, June 27th. Humana's dividend payout ratio (DPR) is presently 35.58%.

Wall Street Analysts Forecast Growth

A number of brokerages recently weighed in on HUM. Mizuho upped their price objective on Humana from $305.00 to $316.00 and gave the stock an "outperform" rating in a report on Wednesday, April 9th. JPMorgan Chase & Co. cut their price target on Humana from $257.00 to $256.00 and set a "neutral" rating for the company in a research note on Tuesday, February 18th. Morgan Stanley lowered their price target on shares of Humana from $301.00 to $285.00 and set an "equal weight" rating on the stock in a research report on Wednesday, February 12th. Raymond James upgraded Humana from a "market perform" rating to an "outperform" rating and set a $315.00 price objective for the company in a research report on Thursday. Finally, Cantor Fitzgerald reiterated a "neutral" rating and set a $290.00 target price on shares of Humana in a report on Thursday. Eighteen research analysts have rated the stock with a hold rating and seven have given a buy rating to the company's stock. According to data from MarketBeat.com, the stock presently has a consensus rating of "Hold" and a consensus price target of $287.76.

About Humana

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.